Global Biosimilar Drug Market Growth 2020-2025

Publisher Name :
Date: 16-Sep-2020
No. of pages: 132

According to this study, over the next five years the Biosimilar Drug market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biosimilar Drug business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilar Drug market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Biosimilar Drug, covering the supply chain analysis, impact assessment to the Biosimilar Drug market size growth rate in several scenarios, and the measures to be undertaken by Biosimilar Drug companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- Injection

- Tablets

- Other Types

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Ankylosing Spondylitis

- Tumor

- Rheumatoid Arthrtis

- Cardiovascular

- Other Application

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Amgen

- Eli Lilly

- CP Guojian Pharma

- Biotech Pharma

- Novartis

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Biosimilar Drug consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Biosimilar Drug market by identifying its various subsegments.

- Focuses on the key global Biosimilar Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Biosimilar Drug with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Biosimilar Drug submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Biosimilar Drug Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biosimilar Drug Consumption 2015-2025
2.1.2 Biosimilar Drug Consumption CAGR by Region
2.2 Biosimilar Drug Segment by Type
2.2.1 Injection
2.2.2 Tablets
2.2.3 Other Types
2.3 Biosimilar Drug Consumption by Type
2.3.1 Global Biosimilar Drug Consumption Market Share by Type (2015-2020)
2.3.2 Global Biosimilar Drug Revenue and Market Share by Type (2015-2020)
2.3.3 Global Biosimilar Drug Sale Price by Type (2015-2020)
2.4 Biosimilar Drug Segment by Application
2.4.1 Ankylosing Spondylitis
2.4.2 Tumor
2.4.3 Rheumatoid Arthrtis
2.4.4 Cardiovascular
2.4.5 Other Application
2.5 Biosimilar Drug Consumption by Application
2.5.1 Global Biosimilar Drug Consumption Market Share by Type (2015-2020)
2.5.2 Global Biosimilar Drug Value and Market Share by Type (2015-2020)
2.5.3 Global Biosimilar Drug Sale Price by Type (2015-2020)

3 Global Biosimilar Drug by Company
3.1 Global Biosimilar Drug Sales Market Share by Company
3.1.1 Global Biosimilar Drug Sales by Company (2018-2020)
3.1.2 Global Biosimilar Drug Sales Market Share by Company (2018-2020)
3.2 Global Biosimilar Drug Revenue Market Share by Company
3.2.1 Global Biosimilar Drug Revenue by Company (2018-2020)
3.2.2 Global Biosimilar Drug Revenue Market Share by Company (2018-2020)
3.3 Global Biosimilar Drug Sale Price by Company
3.4 Global Biosimilar Drug Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Biosimilar Drug Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Biosimilar Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Biosimilar Drug by Regions
4.1 Biosimilar Drug by Regions
4.2 Americas Biosimilar Drug Consumption Growth
4.3 APAC Biosimilar Drug Consumption Growth
4.4 Europe Biosimilar Drug Consumption Growth
4.5 Middle East & Africa Biosimilar Drug Consumption Growth

5 Americas
5.1 Americas Biosimilar Drug Consumption by Countries
5.1.1 Americas Biosimilar Drug Consumption by Countries (2015-2020)
5.1.2 Americas Biosimilar Drug Value by Countries (2015-2020)
5.2 Americas Biosimilar Drug Consumption by Type
5.3 Americas Biosimilar Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Biosimilar Drug Consumption by Regions
6.1.1 APAC Biosimilar Drug Consumption by Regions (2015-2020)
6.1.2 APAC Biosimilar Drug Value by Regions (2015-2020)
6.2 APAC Biosimilar Drug Consumption by Type
6.3 APAC Biosimilar Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Biosimilar Drug by Countries
7.1.1 Europe Biosimilar Drug Consumption by Countries (2015-2020)
7.1.2 Europe Biosimilar Drug Value by Countries (2015-2020)
7.2 Europe Biosimilar Drug Consumption by Type
7.3 Europe Biosimilar Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Biosimilar Drug by Countries
8.1.1 Middle East & Africa Biosimilar Drug Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Biosimilar Drug Value by Countries (2015-2020)
8.2 Middle East & Africa Biosimilar Drug Consumption by Type
8.3 Middle East & Africa Biosimilar Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Biosimilar Drug Distributors
10.3 Biosimilar Drug Customer

11 Global Biosimilar Drug Market Forecast
11.1 Global Biosimilar Drug Consumption Forecast (2021-2025)
11.2 Global Biosimilar Drug Forecast by Regions
11.2.1 Global Biosimilar Drug Forecast by Regions (2021-2025)
11.2.2 Global Biosimilar Drug Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Biosimilar Drug Forecast by Type
11.8 Global Biosimilar Drug Forecast by Application

12 Key Players Analysis
12.1 Amgen
12.1.1 Company Information
12.1.2 Biosimilar Drug Product Offered
12.1.3 Amgen Biosimilar Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Amgen Latest Developments
12.2 Eli Lilly
12.2.1 Company Information
12.2.2 Biosimilar Drug Product Offered
12.2.3 Eli Lilly Biosimilar Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Eli Lilly Latest Developments
12.3 CP Guojian Pharma
12.3.1 Company Information
12.3.2 Biosimilar Drug Product Offered
12.3.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 CP Guojian Pharma Latest Developments
12.4 Biotech Pharma
12.4.1 Company Information
12.4.2 Biosimilar Drug Product Offered
12.4.3 Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Biotech Pharma Latest Developments
12.5 Novartis
12.5.1 Company Information
12.5.2 Biosimilar Drug Product Offered
12.5.3 Novartis Biosimilar Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Novartis Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Biosimilar Drug Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Injection
Table 5. Major Players of Tablets
Table 6. Major Players of Other Types
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Biosimilar Drug Consumption Market Share by Type (2015-2020)
Table 9. Global Biosimilar Drug Revenue by Type (2015-2020) ($ million)
Table 10. Global Biosimilar Drug Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Biosimilar Drug Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Biosimilar Drug Consumption Market Share by Application (2015-2020)
Table 14. Global Biosimilar Drug Value by Application (2015-2020)
Table 15. Global Biosimilar Drug Value Market Share by Application (2015-2020)
Table 16. Global Biosimilar Drug Sale Price by Application (2015-2020)
Table 17. Global Biosimilar Drug Sales by Company (2017-2019) (K Dose)
Table 18. Global Biosimilar Drug Sales Market Share by Company (2017-2019)
Table 19. Global Biosimilar Drug Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Biosimilar Drug Revenue Market Share by Company (2017-2019)
Table 21. Global Biosimilar Drug Sale Price by Company (2017-2019)
Table 22. Global Biosimilar Drug Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Biosimilar Drug Products Offered
Table 24. Biosimilar Drug Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Biosimilar Drug Consumption by Regions 2015-2020 (K Dose)
Table 26. Global Biosimilar Drug Consumption Market Share by Regions 2015-2020
Table 27. Global Biosimilar Drug Value by Regions 2015-2020 ($ Millions)
Table 28. Global Biosimilar Drug Value Market Share by Regions 2015-2020
Table 29. Americas Biosimilar Drug Consumption by Countries (2015-2020) (K Dose)
Table 30. Americas Biosimilar Drug Consumption Market Share by Countries (2015-2020)
Table 31. Americas Biosimilar Drug Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Biosimilar Drug Value Market Share by Countries (2015-2020)
Table 33. Americas Biosimilar Drug Consumption by Type (2015-2020) (K Dose)
Table 34. Americas Biosimilar Drug Consumption Market Share by Type (2015-2020)
Table 35. Americas Biosimilar Drug Consumption by Application (2015-2020) (K Dose)
Table 36. Americas Biosimilar Drug Consumption Market Share by Application (2015-2020)
Table 37. APAC Biosimilar Drug Consumption by Countries (2015-2020) (K Dose)
Table 38. APAC Biosimilar Drug Consumption Market Share by Countries (2015-2020)
Table 39. APAC Biosimilar Drug Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Biosimilar Drug Value Market Share by Regions (2015-2020)
Table 41. APAC Biosimilar Drug Consumption by Type (2015-2020) (K Dose)
Table 42. APAC Biosimilar Drug Consumption Market Share by Type (2015-2020)
Table 43. APAC Biosimilar Drug Consumption by Application (2015-2020) (K Dose)
Table 44. APAC Biosimilar Drug Consumption Market Share by Application (2015-2020)
Table 45. Europe Biosimilar Drug Consumption by Countries (2015-2020) (K Dose)
Table 46. Europe Biosimilar Drug Consumption Market Share by Countries (2015-2020)
Table 47. Europe Biosimilar Drug Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Biosimilar Drug Value Market Share by Countries (2015-2020)
Table 49. Europe Biosimilar Drug Consumption by Type (2015-2020) (K Dose)
Table 50. Europe Biosimilar Drug Consumption Market Share by Type (2015-2020)
Table 51. Europe Biosimilar Drug Consumption by Application (2015-2020) (K Dose)
Table 52. Europe Biosimilar Drug Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Biosimilar Drug Consumption by Countries (2015-2020) (K Dose)
Table 54. Middle East & Africa Biosimilar Drug Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Biosimilar Drug Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Biosimilar Drug Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Biosimilar Drug Consumption by Type (2015-2020) (K Dose)
Table 58. Middle East & Africa Biosimilar Drug Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Biosimilar Drug Consumption by Application (2015-2020) (K Dose)
Table 60. Middle East & Africa Biosimilar Drug Consumption Market Share by Application (2015-2020)
Table 61. Biosimilar Drug Distributors List
Table 62. Biosimilar Drug Customer List
Table 63. Global Biosimilar Drug Consumption Forecast by Countries (2021-2025) (K Dose)
Table 64. Global Biosimilar Drug Consumption Market Forecast by Regions
Table 65. Global Biosimilar Drug Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Biosimilar Drug Value Market Share Forecast by Regions
Table 67. Global Biosimilar Drug Consumption Forecast by Type (2021-2025) (K Dose)
Table 68. Global Biosimilar Drug Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Biosimilar Drug Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Biosimilar Drug Value Market Share Forecast by Type (2021-2025)
Table 71. Global Biosimilar Drug Consumption Forecast by Application (2021-2025) (K Dose)
Table 72. Global Biosimilar Drug Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Biosimilar Drug Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Biosimilar Drug Value Market Share Forecast by Application (2021-2025)
Table 75. Amgen Product Offered
Table 76. Amgen Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 77. Amgen Main Business
Table 78. Amgen Latest Developments
Table 79. Amgen Basic Information, Company Total Revenue (in $ million), Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. Eli Lilly Product Offered
Table 81. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 82. Eli Lilly Main Business
Table 83. Eli Lilly Latest Developments
Table 84. Eli Lilly Basic Information, Company Total Revenue (in $ million), Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. CP Guojian Pharma Product Offered
Table 86. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 87. CP Guojian Pharma Main Business
Table 88. CP Guojian Pharma Latest Developments
Table 89. CP Guojian Pharma Basic Information, Company Total Revenue (in $ million), Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Biotech Pharma Product Offered
Table 91. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 92. Biotech Pharma Main Business
Table 93. Biotech Pharma Latest Developments
Table 94. Biotech Pharma Basic Information, Company Total Revenue (in $ million), Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Novartis Product Offered
Table 96. Novartis Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 97. Novartis Main Business
Table 98. Novartis Latest Developments
Table 99. Novartis Basic Information, Company Total Revenue (in $ million), Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Biosimilar Drug
Figure 2. Biosimilar Drug Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Biosimilar Drug Consumption Growth Rate 2015-2025 (K Dose)
Figure 5. Global Biosimilar Drug Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Injection
Figure 7. Product Picture of Tablets
Figure 8. Product Picture of Other Types
Figure 9. Global Biosimilar Drug Consumption Market Share by Type (2015-2020)
Figure 10. Global Biosimilar Drug Value Market Share by Type (2015-2020)
Figure 11. Biosimilar Drug Consumed in Ankylosing Spondylitis
Figure 12. Global Biosimilar Drug Market: Ankylosing Spondylitis (2015-2020) (K Dose)
Figure 13. Global Biosimilar Drug Market: Ankylosing Spondylitis (2015-2020) ($ Millions)
Figure 14. Biosimilar Drug Consumed in Tumor
Figure 15. Global Biosimilar Drug Market: Tumor (2015-2020) (K Dose)
Figure 16. Global Biosimilar Drug Market: Tumor (2015-2020) ($ Millions)
Figure 17. Biosimilar Drug Consumed in Rheumatoid Arthrtis
Figure 18. Global Biosimilar Drug Market: Rheumatoid Arthrtis (2015-2020) (K Dose)
Figure 19. Global Biosimilar Drug Market: Rheumatoid Arthrtis (2015-2020) ($ Millions)
Figure 20. Biosimilar Drug Consumed in Cardiovascular
Figure 21. Global Biosimilar Drug Market: Cardiovascular (2015-2020) (K Dose)
Figure 22. Global Biosimilar Drug Market: Cardiovascular (2015-2020) ($ Millions)
Figure 23. Biosimilar Drug Consumed in Other Application
Figure 24. Global Biosimilar Drug Market: Other Application (2015-2020) (K Dose)
Figure 25. Global Biosimilar Drug Market: Other Application (2015-2020) ($ Millions)
Figure 26. Global Biosimilar Drug Consumption Market Share by Application (2015-2020)
Figure 27. Global Biosimilar Drug Value Market Share by Application (2015-2020)
Figure 28. Global Biosimilar Drug Sales Market Share by Company in 2017
Figure 29. Global Biosimilar Drug Sales Market Share by Company in 2019
Figure 30. Global Biosimilar Drug Revenue Market Share by Company in 2017
Figure 31. Global Biosimilar Drug Revenue Market Share by Company in 2019
Figure 32. Global Biosimilar Drug Sale Price by Company in 2019
Figure 33. Global Biosimilar Drug Consumption Market Share by Regions 2015-2020
Figure 34. Global Biosimilar Drug Value Market Share by Regions 2015-2020
Figure 35. Americas Biosimilar Drug Consumption 2015-2020 (K Dose)
Figure 36. Americas Biosimilar Drug Value 2015-2020 ($ Millions)
Figure 37. APAC Biosimilar Drug Consumption 2015-2020 (K Dose)
Figure 38. APAC Biosimilar Drug Value 2015-2020 ($ Millions)
Figure 39. Europe Biosimilar Drug Consumption 2015-2020 (K Dose)
Figure 40. Europe Biosimilar Drug Value 2015-2020 ($ Millions)
Figure 41. Middle East & Africa Biosimilar Drug Consumption 2015-2020 (K Dose)
Figure 42. Middle East & Africa Biosimilar Drug Value 2015-2020 ($ Millions)
Figure 43. Americas Biosimilar Drug Consumption Market Share by Countries in 2019
Figure 44. Americas Biosimilar Drug Value Market Share by Countries in 2019
Figure 45. Americas Biosimilar Drug Consumption Market Share by Type in 2019
Figure 46. Americas Biosimilar Drug Consumption Market Share by Application in 2019
Figure 47. United States Biosimilar Drug Consumption Growth 2015-2020 (K Dose)
Figure 48. United States Biosimilar Drug Value Growth 2015-2020 ($ Millions)
Figure 49. Canada Biosimilar Drug Consumption Growth 2015-2020 (K Dose)
Figure 50. Canada Biosimilar Drug Value Growth 2015-2020 ($ Millions)
Figure 51. Mexico Biosimilar Drug Consumption Growth 2015-2020 (K Dose)
Figure 52. Mexico Biosimilar Drug Value Growth 2015-2020 ($ Millions)
Figure 53. APAC Biosimilar Drug Consumption Market Share by Countries in 2019
Figure 54. APAC Biosimilar Drug Value Market Share by Regions in 2019
Figure 55. APAC Biosimilar Drug Consumption Market Share by Type in 2019
Figure 56. APAC Biosimilar Drug Consumption Market Share by Application in 2019
Figure 57. China Biosimilar Drug Consumption Growth 2015-2020 (K Dose)
Figure 58. China Biosimilar Drug Value Growth 2015-2020 ($ Millions)
Figure 59. Japan Biosimilar Drug Consumption Growth 2015-2020 (K Dose)
Figure 60. Japan Biosimilar Drug Value Growth 2015-2020 ($ Millions)
Figure 61. Korea Biosimilar Drug Consumption Growth 2015-2020 (K Dose)
Figure 62. Korea Biosimilar Drug Value Growth 2015-2020 ($ Millions)
Figure 63. Southeast Asia Biosimilar Drug Consumption Growth 2015-2020 (K Dose)
Figure 64. Southeast Asia Biosimilar Drug Value Growth 2015-2020 ($ Millions)
Figure 65. India Biosimilar Drug Consumption Growth 2015-2020 (K Dose)
Figure 66. India Biosimilar Drug Value Growth 2015-2020 ($ Millions)
Figure 67. Australia Biosimilar Drug Consumption Growth 2015-2020 (K Dose)
Figure 68. Australia Biosimilar Drug Value Growth 2015-2020 ($ Millions)
Figure 69. Europe Biosimilar Drug Consumption Market Share by Countries in 2019
Figure 70. Europe Biosimilar Drug Value Market Share by Countries in 2019
Figure 71. Europe Biosimilar Drug Consumption Market Share by Type in 2019
Figure 72. Europe Biosimilar Drug Consumption Market Share by Application in 2019
Figure 73. Germany Biosimilar Drug Consumption Growth 2015-2020 (K Dose)
Figure 74. Germany Biosimilar Drug Value Growth 2015-2020 ($ Millions)
Figure 75. France Biosimilar Drug Consumption Growth 2015-2020 (K Dose)
Figure 76. France Biosimilar Drug Value Growth 2015-2020 ($ Millions)
Figure 77. UK Biosimilar Drug Consumption Growth 2015-2020 (K Dose)
Figure 78. UK Biosimilar Drug Value Growth 2015-2020 ($ Millions)
Figure 79. Italy Biosimilar Drug Consumption Growth 2015-2020 (K Dose)
Figure 80. Italy Biosimilar Drug Value Growth 2015-2020 ($ Millions)
Figure 81. Russia Biosimilar Drug Consumption Growth 2015-2020 (K Dose)
Figure 82. Russia Biosimilar Drug Value Growth 2015-2020 ($ Millions)
Figure 83. Middle East & Africa Biosimilar Drug Consumption Market Share by Countries in 2019
Figure 84. Middle East & Africa Biosimilar Drug Value Market Share by Countries in 2019
Figure 85. Middle East & Africa Biosimilar Drug Consumption Market Share by Type in 2019
Figure 86. Middle East & Africa Biosimilar Drug Consumption Market Share by Application in 2019
Figure 87. Egypt Biosimilar Drug Consumption Growth 2015-2020 (K Dose)
Figure 88. Egypt Biosimilar Drug Value Growth 2015-2020 ($ Millions)
Figure 89. South Africa Biosimilar Drug Consumption Growth 2015-2020 (K Dose)
Figure 90. South Africa Biosimilar Drug Value Growth 2015-2020 ($ Millions)
Figure 91. Israel Biosimilar Drug Consumption Growth 2015-2020 (K Dose)
Figure 92. Israel Biosimilar Drug Value Growth 2015-2020 ($ Millions)
Figure 93. Turkey Biosimilar Drug Consumption Growth 2015-2020 (K Dose)
Figure 94. Turkey Biosimilar Drug Value Growth 2015-2020 ($ Millions)
Figure 95. GCC Countries Biosimilar Drug Consumption Growth 2015-2020 (K Dose)
Figure 96. GCC Countries Biosimilar Drug Value Growth 2015-2020 ($ Millions)
Figure 97. Global Biosimilar Drug Consumption Growth Rate Forecast (2021-2025) (K Dose)
Figure 98. Global Biosimilar Drug Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 99. Americas Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 100. Americas Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 101. APAC Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 102. APAC Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 103. Europe Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 104. Europe Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 105. Middle East & Africa Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 106. Middle East & Africa Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 107. United States Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 108. United States Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 109. Canada Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 110. Canada Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 111. Mexico Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 112. Mexico Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 113. Brazil Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 114. Brazil Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 115. China Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 116. China Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 117. Japan Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 118. Japan Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 119. Korea Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 120. Korea Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 121. Southeast Asia Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 122. Southeast Asia Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 123. India Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 124. India Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 125. Australia Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 126. Australia Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 127. Germany Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 128. Germany Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 129. France Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 130. France Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 131. UK Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 132. UK Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 133. Italy Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 134. Italy Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 135. Russia Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 136. Russia Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 137. Spain Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 138. Spain Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 139. Egypt Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 140. Egypt Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 141. South Africa Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 142. South Africa Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 143. Israel Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 144. Israel Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 145. Turkey Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 146. Turkey Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 147. GCC Countries Biosimilar Drug Consumption 2021-2025 (K Dose)
Figure 148. GCC Countries Biosimilar Drug Value 2021-2025 ($ Millions)
Figure 149. Amgen Biosimilar Drug Market Share (2018-2020)
Figure 150. Eli Lilly Biosimilar Drug Market Share (2018-2020)
Figure 151. CP Guojian Pharma Biosimilar Drug Market Share (2018-2020)
Figure 152. Biotech Pharma Biosimilar Drug Market Share (2018-2020)
Figure 153. Novartis Biosimilar Drug Market Share (2018-2020)
  • Global and United States Adalimumab Biosimilar Market Insights, Forecast to 2026
    Published: 21-Sep-2020        Price: US 3900 Onwards        Pages: 140
    Adalimumab Biosimilar market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Adalimumab Biosimilar market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Adalimumab Biosimilar market ......
  • (COVID-19 Version) Global Oncology Biosimilars Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 20-Sep-2020        Price: US 3000 Onwards        Pages: 95
    Summary The report forecast global Oncology Biosimilars market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Oncology Biosimilars industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Oncology Biosimilars......
  • Global Biosimilar Drug Market Growth 2020-2025
    Published: 16-Sep-2020        Price: US 3660 Onwards        Pages: 132
    According to this study, over the next five years the Biosimilar Drug market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biosimilar Drug business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilar Drug market by product type, a......
  • COVID-19 World Adalimumab Biosimilar Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 13-Sep-2020        Price: US 2800 Onwards        Pages: 94
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Adalimumab Biosimilar , covering Global ......
  • 2020-2029 Report on Global Biosimilar Drug Market by Player, Region, Type, Application and Sales Channel
    Published: 07-Sep-2020        Price: US 2500 Onwards        Pages: 121
    The global Biosimilar Drug market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2020 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this industry......
  • COVID-19 World Oncology Biosimilars Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 05-Sep-2020        Price: US 2800 Onwards        Pages: 98
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Oncology Biosimilars , covering Global t......
  • (COVID-19 Version) Global Biologics and Biosimilars Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 04-Sep-2020        Price: US 3000 Onwards        Pages: 132
    Summary A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product t......
  • (COVID-19 Version) Global Biosimilars Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 03-Sep-2020        Price: US 3000 Onwards        Pages: 98
    Summary A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company. The report forecast global Biosimilars market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Biosimilars industry and main marke......
  • Global Biosimilar Monoclonal Antibodies Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026
    Published: 02-Sep-2020        Price: US 5900 Onwards        Pages: 116
    Biosimilar Monoclonal Antibodies market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Biosimilar Monoclonal Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026. Segment by Type,......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs